Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes
Annals of Neurology · 2023-09 · 94 (3) · 486-501
DOI: 10.1002/ana.26719 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Neurology, online erschienen am 08.07.2023. Verfasst von Natalia Palacios und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health, University of Massachusetts Lowell, Lowell, MA. Hauptthemen laut MEDLINE: Parkinson Disease, Gastrointestinal Microbiome. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NINDS NIH HHS.
Abstract (Originalsprache)
Objective
Prior studies on the gut microbiome in Parkinson's disease (PD) have yielded conflicting results, and few studies have focused on prodromal (premotor) PD or used shotgun metagenomic profiling to assess microbial functional potential. We conducted a nested case–control study within 2 large epidemiological cohorts to examine the role of the gut microbiome in PD.
Methods
We profiled the fecal metagenomes of 420 participants in the Nurses' Health Study and the Health Professionals Follow‐up Study with recent onset PD (N = 75), with features of prodromal PD (N = 101), controls with constipation (N = 113), and healthy controls (N = 131) to identify microbial taxonomic and functional features associated with PD and features suggestive of prodromal PD. Omnibus and feature‐wise analyses identified bacterial species and pathways associated with prodromal and recently onset PD.
Results
We observed depletion of several strict anaerobes associated with reduced inflammation among participants with PD or features of prodromal PD. A microbiome‐based classifier had moderate accuracy (area under the curve [AUC] = 0.76 for species and 0.74 for pathways) to discriminate between recently onset PD cases and controls. These taxonomic shifts corresponded with functional shifts indicative of carbohydrate source preference. Similar, but less marked, changes were observed in participants with features of prodromal PD, in both microbial features and functions.
Interpretation
PD and features of prodromal PD were associated with similar changes in the gut microbiome. These findings suggest that changes in the microbiome could represent novel biomarkers for the earliest phases of PD. ANN NEUROL 2023;94:486–501
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Public Health, University of Massachusetts Lowell, Lowell, MA.
- Department of Veterans Affairs, ENRM VA Hospital, Bedford, MA.
- Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA.
- Harvard Chan Microbiome in Public Health Center (HCMPH), Boston, MA.
- Department of Neurology, Massachusetts General Hospital, Boston, MA.
- Broad Institute of MIT and Harvard, Cambridge, MA.
ORCID-Profile: Natalia Palacios, Kjetil Bjornevik, Michael A Schwarzschild
Förderung
- NIH HHS
- NCI NIH HHS
- NINDS NIH HHS
- National Institute of Neurological Disorders and Stroke
- National Institutes of Health
Zitieren
APA
Palacios, N., Wilkinson, J., Bjornevik, K., Schwarzschild, M. A., McIver, L., Ascherio, A., & Huttenhower, C. (2023). Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes. Annals of Neurology, 94(3), 486-501. https://doi.org/10.1002/ana.26719
Vancouver
Palacios N, Wilkinson J, Bjornevik K, Schwarzschild MA, McIver L, Ascherio A, et al. Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes. Annals of Neurology. 2023;94(3):486-501. doi:10.1002/ana.26719
BibTeX
@article{Palacios2023,
author = {Palacios, Natalia and Wilkinson, Jeremy and Bjornevik, Kjetil and Schwarzschild, Michael A and McIver, Lauren and Ascherio, Alberto and Huttenhower, Curtis},
title = {Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal Changes},
journal = {Annals of Neurology},
year = {2023},
volume = {94},
number = {3},
pages = {486--501},
doi = {10.1002/ana.26719}
}
EUVIMED